We are live on ! Find out more
TTPH

Tetraphase Pharmaceuticals, Inc.
TTPH

Delisted

TTPH was delisted on the 28th of July, 2020.

Back to rankings

90 hedge funds and large institutions have $152M invested in Tetraphase Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 23

1% more funds holding

Funds holding: 89 → 90 (+1)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

11% less capital invested

Capital invested by funds: $170M → $152M (-$18.1M)

43% less call options, than puts

Call options by funds: $2.88M | Put options by funds: $5.09M

Holders
90
Holders Change
+1
Holders Change %
+1.12%
% of All Funds
2.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
27
Reduced
23
Closed
16
Calls
$2.88M
Puts
$5.09M
Net Calls
-$2.21M
Net Calls Change
-$3.38M

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$5.43M
2
EC
EcoR1 Capital
California
+$4.89M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.61M
4
OM
Opaleye Management
Massachusetts
+$2.55M
5
Millennium Management
Millennium Management
New York
+$2.18M

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.95M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.7M
3
Two Sigma Investments
Two Sigma Investments
New York
-$867K
4
BCM
Bridgeway Capital Management
Texas
-$580K
5
TCIM
TIAA CREF Investment Management
New York
-$477K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$16.9M +$524K +3,392 +3%
Canada Pension Plan Investment Board
2
Canada Pension Plan Investment Board
Ontario, Canada
$11.8M – – –
Wellington Management Group
3
Wellington Management Group
Massachusetts
$11.2M +$628K +4,064 +5%
Vanguard Group
4
Vanguard Group
Pennsylvania
$10.1M -$1.7M -10,995 -13%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$9.53M -$321K -2,080 -3%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$7.85M +$3.61M +23,348 +74%
TCM
7
Tekla Capital Management
Massachusetts
$7.16M – – –
Northern Trust
8
Northern Trust
Illinois
$6.32M +$314K +2,033 +5%
NI
9
Numeric Investors
Massachusetts
$5.38M +$5.43M +35,140 +1,363%
State Street
10
State Street
Massachusetts
$5.17M +$337K +2,178 +6%
RSCM
11
Rock Springs Capital Management
Maryland
$4.98M – – –
EC
12
EcoR1 Capital
California
$4.52M +$4.89M +31,670 New
EAM
13
Eventide Asset Management
Massachusetts
$4.28M – – –
Millennium Management
14
Millennium Management
New York
$4.21M +$2.18M +14,109 +91%
Morgan Stanley
15
Morgan Stanley
New York
$2.86M +$647K +4,185 +26%
OM
16
Opaleye Management
Massachusetts
$2.35M +$2.55M +16,500 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$2.29M +$64K +414 +3%
RPAM
18
Rhenman & Partners Asset Management
Sweden
$2.14M – – –
Hudson Bay Capital Management
19
Hudson Bay Capital Management
Connecticut
$1.96M +$2.12M +13,734 New
Balyasny Asset Management
20
Balyasny Asset Management
Illinois
$1.76M +$223K +1,440 +13%
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$1.73M +$37.1K +240 +2%
DAM
22
DLD Asset Management
New York
$1.64M +$1.78M +11,500 New
Federated Hermes
23
Federated Hermes
Pennsylvania
$1.47M +$320K +2,069 +25%
CS
24
Candriam SCA
Luxembourg
$1.43M – – –
Bank of New York Mellon
25
Bank of New York Mellon
New York
$1.38M +$48.2K +312 +3%
1
2 3 4 5

TTPH Hedge Fund Activity: Q2 2017 in Review

90 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q2 2017, worth a combined $152M — down 11% from $170M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new TTPH positions and 16 closed out — a net gain of 1 holder — while 27 added to existing stakes and 23 trimmed.

The largest buyer was Numeric Investors, adding an estimated $5.43M. The largest seller was Acadian Asset Management, cutting an estimated $1.95M.

  • 90 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q2 2017, up from 89 in Q1 2017.
  • Funds reported $152M of Tetraphase Pharmaceuticals, Inc. stock for Q2 2017, down 11% quarter-over-quarter.
  • 17 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q2 2017 and 16 closed out, a net change of +1 holder.
  • The largest Tetraphase Pharmaceuticals, Inc. buyer in Q2 2017 was Numeric Investors, an estimated $5.43M added.
  • The largest Tetraphase Pharmaceuticals, Inc. seller in Q2 2017 was Acadian Asset Management, an estimated $1.95M sold.

Based on aggregated 13F filings for Q2 2017.